
Merrimack Pharmaceuticals, Inc. – NASDAQ:MACK
Merrimack Pharmaceuticals stock price monthly change
Merrimack Pharmaceuticals stock price quarterly change
Merrimack Pharmaceuticals stock price yearly change
Merrimack Pharmaceuticals key metrics
Market Cap | 223.97M |
Enterprise value | N/A |
P/E | -8.91 |
EV/Sales | N/A |
EV/EBITDA | 4.51 |
Price/Sales | N/A |
Price/Book | 0.98 |
PEG ratio | 0.27 |
EPS | -1.70 |
Revenue | N/A |
EBITDA | -2.25M |
Income | -24.54M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMerrimack Pharmaceuticals stock price history
Merrimack Pharmaceuticals stock forecast
Merrimack Pharmaceuticals financial statements
Jun 2023 | 0 | -391K | |
---|---|---|---|
Sep 2023 | 0 | -279K | |
Dec 2023 | 0 | -240K | |
Mar 2024 | 0 | -23.63M |
Payout ratio | 0% |
---|
2019 | 63.48% |
---|---|
2020 | |
2021 | |
2022 | |
2023 |
Jun 2023 | 19448000 | 411K | 2.11% |
---|---|---|---|
Sep 2023 | 19299000 | 493K | 2.55% |
Dec 2023 | 19188000 | 441K | 2.3% |
Mar 2024 | 244322000 | 22.67M | 9.28% |
Jun 2023 | -668K | -8.81M | 209K |
---|---|---|---|
Sep 2023 | -203K | -3.84M | 0 |
Dec 2023 | -295K | 68K | 133K |
Mar 2024 | -1.31M | 228M | 1.48M |
Merrimack Pharmaceuticals other data
Period | Buy | Sel |
---|---|---|
Jan 2023 | 189353 | 0 |
Mar 2023 | 160590 | 0 |
Aug 2023 | 225550 | 0 |
Nov 2023 | 74268 | 0 |
Dec 2023 | 150600 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | ANDERSEN ERIC director | Common Stock | 857 | $13.35 | $11,441 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 48,693 | $13.15 | $640,313 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 76,384 | $12.85 | $981,534 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 24,666 | $12.85 | $316,958 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 235 | $12.5 | $2,938 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 65 | $12.5 | $813 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 39,283 | $12.5 | $491,038 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 10,887 | $12.5 | $136,088 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 7,810 | $12.19 | $95,220 | ||
Purchase | ANDERSEN ERIC director | Common Stock | 2,165 | $12.19 | $26,396 |
Patent |
---|
Application Filling date: 28 Feb 2020 Issue date: 8 Sep 2022 |
Application Filling date: 18 Sep 2019 Issue date: 2 Dec 2021 |
Application Filling date: 16 Mar 2017 Issue date: 3 Oct 2019 |
Application Filling date: 5 Nov 2018 Issue date: 26 Sep 2019 |
Quarter | Transcript |
---|---|
Q3 2018 7 Nov 2018 | Q3 2018 Earnings Call Transcript |
Q2 2018 7 Aug 2018 | Q2 2018 Earnings Call Transcript |
Q1 2018 8 May 2018 | Q1 2018 Earnings Call Transcript |
Q4 2017 12 Mar 2018 | Q4 2017 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. Ulrik B. Nielsen (1972) Co-Founder & Independent Director | $76,880 |
Mr. Gary L. Crocker M.B.A., MBA (1952) Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, Chief Executive Officer & Chairman | $74,500 |
-
When is Merrimack Pharmaceuticals's next earnings date?
Unfortunately, Merrimack Pharmaceuticals's (MACK) next earnings date is currently unknown.
-
Does Merrimack Pharmaceuticals pay dividends?
Yes, Merrimack Pharmaceuticals pays dividends and its trailing 12-month yield is 199.41% with 0% payout ratio. The last Merrimack Pharmaceuticals stock dividend of $0.5 was paid on 23 Dec 2019.
-
How much money does Merrimack Pharmaceuticals make?
Merrimack Pharmaceuticals has a market capitalization of 223.97M.
-
What is Merrimack Pharmaceuticals's stock symbol?
Merrimack Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "MACK".
-
What is Merrimack Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Merrimack Pharmaceuticals?
Shares of Merrimack Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Merrimack Pharmaceuticals's key executives?
Merrimack Pharmaceuticals's management team includes the following people:
- Dr. Ulrik B. Nielsen Co-Founder & Independent Director(age: 53, pay: $76,880)
- Mr. Gary L. Crocker M.B.A., MBA Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, Chief Executive Officer & Chairman(age: 73, pay: $74,500)
-
Is Merrimack Pharmaceuticals founder-led company?
Yes, Merrimack Pharmaceuticals is a company led by its founder Dr. Ulrik B. Nielsen.
-
When Merrimack Pharmaceuticals went public?
Merrimack Pharmaceuticals, Inc. is publicly traded company for more then 13 years since IPO on 29 Mar 2012.
-
What is Merrimack Pharmaceuticals's official website?
The official website for Merrimack Pharmaceuticals is merrimack.com.
-
Where are Merrimack Pharmaceuticals's headquarters?
Merrimack Pharmaceuticals is headquartered at One Broadway, Cambridge, MA.
-
How can i contact Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals's mailing address is One Broadway, Cambridge, MA and company can be reached via phone at +61 77208606.
Merrimack Pharmaceuticals company profile:

Merrimack Pharmaceuticals, Inc.
merrimack.comNASDAQ
0
Biotechnology
Healthcare
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Cambridge, MA 02142
CIK: 0001274792
ISIN: US5903282094
CUSIP: 590328209